Dr. Yasmin Thanavala on targeted therapy for liver cancer
2 Visninger
• 06/28/23
0
0
Indlejre
administrator
Abonnenter
Yasmin Thanavala, PhD, of the Department of Immunology and the Tumor Immunology and Immunotherapy program at Roswell Park Cancer Institute, discusses new research that may help identify those patients with advanced liver cancer who will benefit most from the targeted therapy sorafenib. Read more: http://goo.gl/W0jPX2
Vis mere
Facebook kommentarer
SORT BY-
Topkommentarer
-
Seneste kommentarer